488 related articles for article (PubMed ID: 8332187)
1. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
[TBL] [Abstract][Full Text] [Related]
2. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
3. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
Leevers SJ; Paterson HF; Marshall CJ
Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
[TBL] [Abstract][Full Text] [Related]
4. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
5. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
[TBL] [Abstract][Full Text] [Related]
6. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
7. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
Marshall M
Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
[TBL] [Abstract][Full Text] [Related]
9. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene.
Li Y; White R
Cancer Res; 1996 Jun; 56(12):2872-6. PubMed ID: 8665528
[TBL] [Abstract][Full Text] [Related]
10. Mutations that abolish the ability of Ha-Ras to associate with Raf-1.
Shirouzu M; Koide H; Fujita-Yoshigaki J; Oshio H; Toyama Y; Yamasaki K; Fuhrman SA; Villafranca E; Kaziro Y; Yokoyama S
Oncogene; 1994 Aug; 9(8):2153-7. PubMed ID: 8036000
[TBL] [Abstract][Full Text] [Related]
11. TC21 and Ras share indistinguishable transforming and differentiating activities.
Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
13. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
[TBL] [Abstract][Full Text] [Related]
14. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
Luo Z; Tzivion G; Belshaw PJ; Vavvas D; Marshall M; Avruch J
Nature; 1996 Sep; 383(6596):181-5. PubMed ID: 8774885
[TBL] [Abstract][Full Text] [Related]
15. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1.
Bosch E; Cherwinski H; Peterson D; McMahon M
Oncogene; 1997 Aug; 15(9):1021-33. PubMed ID: 9285556
[TBL] [Abstract][Full Text] [Related]
16. Ras regulatory interactions: novel targets for anti-cancer intervention?
Prendergast GC; Gibbs JB
Bioessays; 1994 Mar; 16(3):187-91. PubMed ID: 8166672
[TBL] [Abstract][Full Text] [Related]
17. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP.
Geyer M; Schweins T; Herrmann C; Prisner T; Wittinghofer A; Kalbitzer HR
Biochemistry; 1996 Aug; 35(32):10308-20. PubMed ID: 8756686
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
